COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,893 Articles (22,568 medRxiv, 8,325 bioRxiv)

Most recent first Previous |  Page 1164: Articles 11631-11640  | Next

Immunogenicity of trimetric spike protein associated to Poly(I:C) plus Alum
Santos, J. d., Cruz, L. F., Fonseca-Martins, A. M. d., Maciel, D. O., Perez, G. G., Roncaglia-Pereira, V. A., Dumard, C. H., Guedes da Silva, F. H., dos Santos, A. C. V., Leandro, M. S., Ferreira, J. R. M., Pinto, K. G., Costa, L. J., Rodrigues, D. A. S., Silva, M. V. M., Alvim, R. G. F., Lima, T. M., Marsili, F. F., Abreu, D. P. B. d., Ferreira, O., Borges, R. d. S. M., Tanuri, A., Souza, T. M. L., Bergmann, B. R., Vale, A. M., Lima, J. S., de Oliveira, A. C., Filardy, A. A., Gomes, A. M. O., de Matos Guedes, H. L.
10.1101/2021.10.05.461434 — Posted: 2021-10-06
Single-cell profiling in COVID-19 associated acute kidney injury reveals patterns of tubule injury and repair in human
Legouis, D., Rinaldi, A., Arnoux, G., Verissimo, T., Scotti-Gerber, J., Faivre, A., Schibler, M., Rinaldi, A., Naesens, M., Koppitch, K., Pugin, J., McMahon, A. P., Moll, S., de Seigneux, S., Cippa, P. E.
10.1101/2021.10.05.463150 — Posted: 2021-10-06
Clinical and immunological signatures of severe COVID-19 in previously healthy patients with clonal hematopoiesis
Jung, I.
10.1101/2021.10.05.463271 — Posted: 2021-10-06
A cell-free assay for rapid screening of inhibitors of hACE2-receptor - SARS-CoV-2-Spike binding
Kikuchi, N., Willinger, O., Granik, N., Navon, N., Ackerman, S., Samuel, E., Antman, T., Katz, N., Goldberg, S., Amit, R.
10.1101/2021.10.06.462907 — Posted: 2021-10-06
How does temperature affect the dynamics of SARS-CoV-2 M proteins? Insights from Molecular Dynamics Simulations
Rath, S. L., Tripathy, M., Mandal, N.
10.1101/2021.10.05.463008 — Posted: 2021-10-06
SARS-CoV-2 causes human BBB injury and neuroinflammation indirectly in a linked organ chip platform
Wang, P., Jin, L., Zhang, M., Wu, Y., Duan, Z., Chen, W., Wang, C., Liao, Z., Han, J., Guo, Y., Guo, Y., Wang, Y., Lai, R., Qin, J.
10.1101/2021.10.05.463205 — Posted: 2021-10-06
Clinical utility of Elecsys Anti-SARS-CoV-2 S assay in COVID-19 vaccination: An exploratory analysis of the mRNA-1273 phase 1 trial
Jochum, S., Kirste, I., Hortsch, S., Grunert, V. P., Legault, H., Eichenlaub, U., Kashlan, B., Pajon, R.
10.1101/2021.10.04.21264521 — Posted: 2021-10-05
COVID-19 aerosol transmission simulation-based risk analysis for in-person learning
Swanson, T., Guikema, S. D., Bagian, J., Schemanske, C., Payne, C.
10.1101/2021.10.04.21263860 — Posted: 2021-10-05
A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity
Perez-Rodriguez, S., Rodriguez-Gonzalez, M. d. l. C., Ochoa-Azze, R., Climent-Ruiz, Y., Gonzalez-Delgado, C. A., Paredes-Moreno, B., Valenzuela-Silva, C., Rodriguez-Noda, L., Perez-Nicado, R., Gonzalez-Mugica, R., Martinez-Perez, M., Sanchez-Ramirez, B., Hernandez-Garcia, T., Diaz-Machado, A., Tamayo-Rodriguez, M., Martin-Trujillo, A., Rubino-Moreno, J., Suarez-Batista, A., Dubed-Echevarria, M., Perez-Guevara, M. T., Amoroto-Roig, M., Chappi-Estevez, Y., Bergado-Baez, G., Pi-Estopinan, F., Chen, G.-W., Valdes-Balbin, Y., Garcia-Rivera, D., Verez-Bencomo, V.
10.1101/2021.10.04.21264522 — Posted: 2021-10-05
Fourteen-days Evolution of COVID-19 Symptoms During the Third Wave in Non-vaccinated Subjects and Effects of Hesperidin Therapy: A randomized, double-blinded, placebo-controlled study.
Dupuis, J., Laurin, P., Tardif, J.-C., Hausermann, L., Rosa, C., Guertin, M.-C., Thibaudeau, K., Gagnon, L., Cesari, F., Robitaille, M., Moran, J. E.
10.1101/2021.10.04.21264483 — Posted: 2021-10-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).